The vocal biomarkers market size has grown rapidly in recent years. It will grow from $3.35 billion in 2025 to $3.98 billion in 2026 at a compound annual growth rate (CAGR) of 18.8%. The growth in the historic period can be attributed to increasing research into digital health biomarkers, growth of telemedicine adoption, availability of advanced speech analytics software, rising focus on mental health screening, expansion of academic research programs.
The vocal biomarkers market size is expected to see rapid growth in the next few years. It will grow to $7.41 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing clinical validation of vocal biomarkers, rising integration with wearable health platforms, expansion of ai-powered diagnostics, growing demand for non-invasive monitoring solutions, increasing regulatory acceptance of digital biomarkers. Major trends in the forecast period include increasing use of AI-driven voice analysis platforms, rising adoption of remote health monitoring tools, growing integration of vocal biomarkers in mental health assessment, expansion of voice-based diagnostic applications, enhanced focus on continuous patient monitoring.
The increasing prevalence of neurological and psychological disorders is expected to drive the growth of the voice biomarkers market in the coming years. Neurological disorders are medical conditions that affect the nervous system, while psychological disorders influence mood, thinking, and behavior. The rise in these disorders can be linked to factors such as heightened stress, aging populations, lifestyle changes, and improved awareness and diagnostic capabilities. Voice biomarkers are used in neurological and psychological disorders to non-invasively detect and monitor disease-specific changes in speech patterns, pitch, and rhythm, offering valuable insights into the onset and progression of these conditions. For example, in April 2024, data published by alzheimers.gov, a US Department of Health and Human Services (HHS) source, indicated that over 6 million Americans aged 65 and above were living with Alzheimer’s disease, a figure projected to exceed 13 million by 2060. Consequently, the growing prevalence of neurological and psychological disorders is fueling the expansion of the voice biomarkers market.
Key players in the vocal biomarkers market are focusing on developing advanced technologies, such as Monitor Vocal Biomarkers, to improve disease detection accuracy, enhance patient monitoring, and enable early intervention for a range of health conditions. Monitor Vocal Biomarkers involves analyzing voice to identify physiological and psychological health indicators. For instance, in November 2024, Sonde Health, a US-based digital health company, launched Sonde Cognitive Fitness, a voice-based cognitive fitness tracker designed to assess cognitive effort in real time. The tracker collects voice samples via most smart devices and analyzes vocal biomarkers to evaluate cognitive workload.
In January 2023, Cambridge Cognition Ltd., a UK-based neuroscience technology firm, acquired Winterlight Labs for approximately $0.0086 billion. This acquisition reinforced Cambridge Cognition’s leadership in the vocal biomarker market, enabling the company to leverage significant growth opportunities by offering a comprehensive suite of voice-based solutions for clinical research and healthcare applications. Winterlight Labs, based in Canada, specializes in vocal biomarkers for evaluating cognitive and mental health conditions.
Major companies operating in the vocal biomarkers market are Beyond Verbal, AudEERING, Sonde Health Inc., Kintsugi Health, Ellipsis Health, Canary Speech, Vocalis Health, EVOCAL Health, Cogito Corporation, ConversationHealth, Veritone Inc., Cambridge Cognition Ltd., Neurotrack Technologies Inc., Winterlight Labs, Aural Analytics, PeakProfiling, Mindstrong Health, Sonic Cloud Health, NeuraMetrix, Aiva Health, Modality AI, VoiceSense, VoxMetrix.
North America was the largest region in the vocal biomarkers market in 2025. The regions covered in the vocal biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vocal biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the vocal biomarkers market by increasing costs of imported semiconductors, microphones, signal processing hardware, and cloud infrastructure components used in voice analysis platforms. Digital health developers in North America and Europe are most affected due to dependence on advanced imported electronics, while Asia-Pacific faces higher costs in device manufacturing and exports. These tariffs are increasing development costs and extending commercialization timelines. However, they are also encouraging local hardware sourcing, regional software innovation, and investment in domestically developed digital health ecosystems.
The vocal biomarkers market research report is one of a series of new reports that provides vocal biomarkers market statistics, including vocal biomarkers industry global market size, regional shares, competitors with a vocal biomarkers market share, detailed vocal biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the vocal biomarkers industry. This vocal biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vocal biomarkers are quantifiable characteristics of the voice that offer insights into an individual’s health and overall well-being. These biomarkers are obtained through the analysis of vocal features such as pitch, tone, rhythm, volume, and speech patterns. They can be employed to detect, monitor, and predict a range of health conditions, including mental health disorders, neurological diseases, and respiratory ailments.
The primary types of vocal biomarkers include frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, and others. Frequency, in particular, refers to the rate at which sound waves vibrate and can reveal information about a person’s health and emotional state. Vocal biomarkers are applied in multiple contexts for monitoring and control purposes. They are utilized across various medical indications, such as psychiatric disorders, neurological disorders, respiratory conditions, cardiovascular diseases, traumatic brain injury (TBI), and more. They serve a diverse population, including children, newborns, and adults. Key end users of vocal biomarkers include hospitals, clinics, academic institutions, research centers, and similar organizations.
The vocal biomarkers market consists of revenues earned by entities by providing services such as diagnostic and monitoring services and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The vocal biomarkers market also includes sales of specialized recording devices, sensors, and integrated systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vocal biomarkers market size is expected to see rapid growth in the next few years. It will grow to $7.41 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing clinical validation of vocal biomarkers, rising integration with wearable health platforms, expansion of ai-powered diagnostics, growing demand for non-invasive monitoring solutions, increasing regulatory acceptance of digital biomarkers. Major trends in the forecast period include increasing use of AI-driven voice analysis platforms, rising adoption of remote health monitoring tools, growing integration of vocal biomarkers in mental health assessment, expansion of voice-based diagnostic applications, enhanced focus on continuous patient monitoring.
The increasing prevalence of neurological and psychological disorders is expected to drive the growth of the voice biomarkers market in the coming years. Neurological disorders are medical conditions that affect the nervous system, while psychological disorders influence mood, thinking, and behavior. The rise in these disorders can be linked to factors such as heightened stress, aging populations, lifestyle changes, and improved awareness and diagnostic capabilities. Voice biomarkers are used in neurological and psychological disorders to non-invasively detect and monitor disease-specific changes in speech patterns, pitch, and rhythm, offering valuable insights into the onset and progression of these conditions. For example, in April 2024, data published by alzheimers.gov, a US Department of Health and Human Services (HHS) source, indicated that over 6 million Americans aged 65 and above were living with Alzheimer’s disease, a figure projected to exceed 13 million by 2060. Consequently, the growing prevalence of neurological and psychological disorders is fueling the expansion of the voice biomarkers market.
Key players in the vocal biomarkers market are focusing on developing advanced technologies, such as Monitor Vocal Biomarkers, to improve disease detection accuracy, enhance patient monitoring, and enable early intervention for a range of health conditions. Monitor Vocal Biomarkers involves analyzing voice to identify physiological and psychological health indicators. For instance, in November 2024, Sonde Health, a US-based digital health company, launched Sonde Cognitive Fitness, a voice-based cognitive fitness tracker designed to assess cognitive effort in real time. The tracker collects voice samples via most smart devices and analyzes vocal biomarkers to evaluate cognitive workload.
In January 2023, Cambridge Cognition Ltd., a UK-based neuroscience technology firm, acquired Winterlight Labs for approximately $0.0086 billion. This acquisition reinforced Cambridge Cognition’s leadership in the vocal biomarker market, enabling the company to leverage significant growth opportunities by offering a comprehensive suite of voice-based solutions for clinical research and healthcare applications. Winterlight Labs, based in Canada, specializes in vocal biomarkers for evaluating cognitive and mental health conditions.
Major companies operating in the vocal biomarkers market are Beyond Verbal, AudEERING, Sonde Health Inc., Kintsugi Health, Ellipsis Health, Canary Speech, Vocalis Health, EVOCAL Health, Cogito Corporation, ConversationHealth, Veritone Inc., Cambridge Cognition Ltd., Neurotrack Technologies Inc., Winterlight Labs, Aural Analytics, PeakProfiling, Mindstrong Health, Sonic Cloud Health, NeuraMetrix, Aiva Health, Modality AI, VoiceSense, VoxMetrix.
North America was the largest region in the vocal biomarkers market in 2025. The regions covered in the vocal biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vocal biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the vocal biomarkers market by increasing costs of imported semiconductors, microphones, signal processing hardware, and cloud infrastructure components used in voice analysis platforms. Digital health developers in North America and Europe are most affected due to dependence on advanced imported electronics, while Asia-Pacific faces higher costs in device manufacturing and exports. These tariffs are increasing development costs and extending commercialization timelines. However, they are also encouraging local hardware sourcing, regional software innovation, and investment in domestically developed digital health ecosystems.
The vocal biomarkers market research report is one of a series of new reports that provides vocal biomarkers market statistics, including vocal biomarkers industry global market size, regional shares, competitors with a vocal biomarkers market share, detailed vocal biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the vocal biomarkers industry. This vocal biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vocal biomarkers are quantifiable characteristics of the voice that offer insights into an individual’s health and overall well-being. These biomarkers are obtained through the analysis of vocal features such as pitch, tone, rhythm, volume, and speech patterns. They can be employed to detect, monitor, and predict a range of health conditions, including mental health disorders, neurological diseases, and respiratory ailments.
The primary types of vocal biomarkers include frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, and others. Frequency, in particular, refers to the rate at which sound waves vibrate and can reveal information about a person’s health and emotional state. Vocal biomarkers are applied in multiple contexts for monitoring and control purposes. They are utilized across various medical indications, such as psychiatric disorders, neurological disorders, respiratory conditions, cardiovascular diseases, traumatic brain injury (TBI), and more. They serve a diverse population, including children, newborns, and adults. Key end users of vocal biomarkers include hospitals, clinics, academic institutions, research centers, and similar organizations.
The vocal biomarkers market consists of revenues earned by entities by providing services such as diagnostic and monitoring services and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The vocal biomarkers market also includes sales of specialized recording devices, sensors, and integrated systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vocal Biomarkers Market Characteristics
3. Vocal Biomarkers Market Supply Chain Analysis
4. Global Vocal Biomarkers Market Trends and Strategies
5. Vocal Biomarkers Market Analysis of End Use Industries
7. Global Vocal Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vocal Biomarkers Total Addressable Market (TAM) Analysis for the Market
9. Vocal Biomarkers Market Segmentation
10. Vocal Biomarkers Market Regional and Country Analysis
11. Asia-Pacific Vocal Biomarkers Market
12. China Vocal Biomarkers Market
13. India Vocal Biomarkers Market
14. Japan Vocal Biomarkers Market
15. Australia Vocal Biomarkers Market
16. Indonesia Vocal Biomarkers Market
17. South Korea Vocal Biomarkers Market
18. Taiwan Vocal Biomarkers Market
19. South East Asia Vocal Biomarkers Market
20. Western Europe Vocal Biomarkers Market
21. UK Vocal Biomarkers Market
22. Germany Vocal Biomarkers Market
23. France Vocal Biomarkers Market
24. Italy Vocal Biomarkers Market
25. Spain Vocal Biomarkers Market
26. Eastern Europe Vocal Biomarkers Market
27. Russia Vocal Biomarkers Market
28. North America Vocal Biomarkers Market
29. USA Vocal Biomarkers Market
30. Canada Vocal Biomarkers Market
31. South America Vocal Biomarkers Market
32. Brazil Vocal Biomarkers Market
33. Middle East Vocal Biomarkers Market
34. Africa Vocal Biomarkers Market
36. Vocal Biomarkers Market Competitive Landscape and Company Profiles
37. Vocal Biomarkers Market Other Major and Innovative Companies
40. Vocal Biomarkers Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Vocal Biomarkers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vocal biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vocal biomarkers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vocal biomarkers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Frequency; Amplitude; Error Rate; Vocal Rise Or Fall Time; Phonation Time; Voice Tremor; Pitch; Other Types2) By Indications: Psychiatric Disorders; Neurological Disorders; Respiratory Disorders; Cardiovascular Disorders; Traumatic Brain Injury (TBI); Other Indications
3) By Consumer: Children And Newborns; Adults
4) By End Users: Hospitals And Clinics; Academic; Research; Other End-Users
Subsegments:
1) By Frequency: Fundamental Frequency (Pitch); Formant Frequencies2) By Amplitude: Intensity Levels; Amplitude Variation
3) By Error Rate: Phonemic Errors; Prosodic Errors
4) By Vocal Rise Or Fall Time: Rise Time Slope; Fall Time Slope
5) By Phonation Time: Sustained Phonation Duration; Phonation Intervals
6) By Voice Tremor: Frequency Modulation Tremor; Amplitude Modulation Tremor
7) By Pitch: Mean Pitch; Pitch Variability
8) By Other Types: Speech Rate; Jitter; Shimmer
Companies Mentioned: Beyond Verbal; AudEERING; Sonde Health Inc.; Kintsugi Health; Ellipsis Health; Canary Speech; Vocalis Health; EVOCAL Health; Cogito Corporation; ConversationHealth; Veritone Inc.; Cambridge Cognition Ltd.; Neurotrack Technologies Inc.; Winterlight Labs; Aural Analytics; PeakProfiling; Mindstrong Health; Sonic Cloud Health; NeuraMetrix; Aiva Health; Modality AI; VoiceSense; VoxMetrix
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vocal Biomarkers market report include:- Beyond Verbal
- AudEERING
- Sonde Health Inc.
- Kintsugi Health
- Ellipsis Health
- Canary Speech
- Vocalis Health
- EVOCAL Health
- Cogito Corporation
- ConversationHealth
- Veritone Inc.
- Cambridge Cognition Ltd.
- Neurotrack Technologies Inc.
- Winterlight Labs
- Aural Analytics
- PeakProfiling
- Mindstrong Health
- Sonic Cloud Health
- NeuraMetrix
- Aiva Health
- Modality AI
- VoiceSense
- VoxMetrix
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.98 Billion |
| Forecasted Market Value ( USD | $ 7.41 Billion |
| Compound Annual Growth Rate | 16.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
